Skip to content

Compliance With Enhanced Recovery After Surgery Protocol (ERAS) in Surgical Patients

Evaluation of Compliance With Enhanced Recovery After Surgery (ERAS) Protocol in Benign Gynecological Surgical Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03968666
Enrollment
100
Registered
2019-05-30
Start date
2019-06-01
Completion date
2022-10-31
Last updated
2022-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Surgery

Brief summary

The concept of enhanced recovery was introduced by European anesthesiologists and surgeons who challenged traditional clinical practices involved in peri-operative care in 1990s. The goal of enhanced recovery programs (ERP) is to maintain normal physiology thereby decreasing complications. It focuses on peri-operative optimization of patient care. It was originally created for open colorectal surgeries but now has shown benefit in various surgical specialities including thoracic surgery, vascular surgery, hepatobiliary as well as gynecological surgery. The successful implementation of structured ERAS program requires an ERAS protocol, audit system and a multidisciplinary team. The investigators will evaluate the effect of compliance with the protocol and outcomes such as length of stay, readmissions, morbidity and mortality.

Detailed description

After approval by the Institutional Review Board, the investigators plan to retrospectively study gynecological patients who underwent ERAS protocol at Augusta University Medical Center between January 2017 and February 2019. This is a retrospective observational study to evaluate the outcomes of patients who had ERAS protocol during their surgery. Demographic and outcome variables will be obtained from the institutional health documentation system. The investigators will collect demographic variables (age, ASA status), morphometric measurements (body mass index), time from enrollment to ERAS protocol, hospitalization length of stay, and readmission rate. The investigators will also record the documentation of the ERAS protocol interventions against the ERAS protocol approved by the institution. The investigators will assess the effect of the degree of compliance on outcome variables.

Interventions

None listed

Sponsors

Augusta University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All elective benign gynecological surgical patients enrolled under ERAS protocol

Exclusion criteria

* History of oncologic pathologies

Design outcomes

Primary

MeasureTime frameDescription
Length of stay2 weeksDays from surgery to discharge from the hospital

Secondary

MeasureTime frameDescription
Readmission2 weeksAdmission to hospital after discharge
Mortality2 weeksNumber of fatalities after surgery

Countries

United States

Contacts

Primary ContactEfrain Riveros Perez, MD
eriverosperez@augusta.edu3304074681

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026